Evidence map›Paper›PMID 33608345›Full record

ArticleBMJ case reports2021

Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission.

Virgilio Galvis, Nathalia J Moreno, Alejandro Tello, Néstor I Carreño

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Virgilio GalvisOphthalmology, Centro Oftalmologico Virgilio Galvis, Floridablanca, Santander, Colombia.
Nathalia J MorenoOphthalmology, Universidad Autonoma de Bucaramanga, Bucaramanga, Santander, Colombia.
Alejandro TelloOphthalmology, Universidad Autonoma de Bucaramanga, Bucaramanga, Santander, Colombia alejandrotello@gmail.com.ORCID http://orcid.org/0000-0001-5081-0720
Néstor I CarreñoOphthalmology, Universidad Autonoma de Bucaramanga, Bucaramanga, Santander, Colombia.
Universidad Autónoma de Bucaramanga · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A man with a history of blind eye due to trauma 22 years earlier consulted at 53 years of age with a large conjunctival neoplastic lesion, compromising almost the entire temporal limbus, and reaching a size of approximately 16 mm on its larger diameter, in the conjunctiva. Management was started with topical and subconjunctival chemotherapy (interferon alpha-2b) in order to perform immunoreduction, but a dramatic response with total disappearance of the lesion was observed. In the follow-up time period of more than 7 years, there were no signs of recurrence.

Indexed as

Administration, TopicalAntineoplastic AgentsCarcinoma, Squamous CellEye NeoplasmsFollow-Up StudiesHumansInterferon alpha-2MaleMiddle AgedTreatment OutcomeAntineoplastic AgentsInterferon alpha-2cancer interventioneyeophthalmology

Identifiers

PMID33608345
PMCPMC7896608
OpenAlexW3131227899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.